In 2022, the global Hormonal Contraceptive Market size reached USD 22.64 Billion, and according to the latest report from Reports and Data, it is projected to experience a 5.9% compound annual growth rate (CAGR) in revenue over the forecast period.
Hormonal contraceptives function by influencing the endocrine system to prevent pregnancy. These methods harness hormones like estrogen and progesterone, which are naturally produced by women, to inhibit ovulation and, consequently, avoid conception.
Additionally, the rising demand for effective birth control methods is a significant driver of revenue growth in this market. Unwanted pregnancies disproportionately affect women in underdeveloped regions, with severe implications for their health, education, and economic well-being. This has led to an increased demand for hormonal contraceptives in these areas.
Access Free sample PDF Copy of the Report @
https://www.reportsanddata.com/download-free-sample/6379
Moreover, the increasing availability of hormonal contraceptives in various forms, such as pills, patches, injections, and vaginal rings, is expected to boost the adoption of hormonal contraception. These diverse options offer women a wide range of choices to meet their specific needs and preferences. Furthermore, the development of innovative hormonal contraceptive products, known for their improved effectiveness and safety profiles, is also fueling the expansion of market revenue.
Key players in the Hormonal Contraceptive Market:
- Bayer AG
- Merck & Co., Inc.
- Pfizer, Inc.
- Allergan plc
- Agile Therapeutics, Inc.
- Mylan N.V.
- Afaxys, Inc.
- Reckitt Benckiser Group plc
- CooperSurgical, Inc.
- Teva Pharmaceutical Industries Ltd.
- Janssen Pharmaceuticals, Inc.
- Ferring Pharmaceuticals, Inc.
- Mithra Pharmaceuticals S.A.
- HRA Pharma
- Syzygy Healthcare plc
Some Key Highlights in the Report:
- In 2022, the global hormonal contraceptive market was dominated by the pills segment in terms of revenue, largely due to the widespread use and popularity of oral contraceptive pills among women worldwide. Oral contraceptive pills offer numerous benefits, including ease of use, high effectiveness, and the ability to reverse their effects. They come in various formulations, including combination pills and progestin-only pills, to cater to the specific needs and preferences of women. Additionally, the increasing awareness and accessibility of these pills through government initiatives and family planning programs are expected to drive up the demand for hormonal contraceptive pills, thereby contributing to revenue growth in this segment.
- Looking ahead, it is estimated that during the forecast period, the combination hormonal contraceptives segment will hold the largest share of revenue in the global hormonal contraceptive market. This is because combined hormonal contraceptives have a high effectiveness rate when used correctly and consistently. They contain both estrogen and progestin hormones, which work together to inhibit ovulation, thicken cervical mucus to prevent sperm from reaching the egg, and thin the uterine lining to prevent the implantation of a fertilized egg. Moreover, they offer additional advantages such as regulating menstrual cycles, reducing menstrual cramps, and treating acne, making them a preferred choice among women.
- In 2022, the Asia Pacific region emerged as the leader in terms of revenue in the hormonal contraceptive market. This can be attributed to several factors, including the growing middle class, increased awareness about family planning, and government initiatives aimed at reducing unplanned pregnancies. Furthermore, the availability of affordable contraceptives through e-commerce platforms, coupled with rising disposable incomes, is expected to drive revenue growth in this region. Countries like Japan, facing the challenge of an aging population, are witnessing a rising demand for hormonal contraceptives to prevent unintended pregnancies among older women.
- Looking forward, the North American market is expected to experience the fastest revenue growth rate in the hormonal contraceptive market during the forecast period. This can be attributed to the increasing awareness of contraception and the importance of preventing unwanted pregnancies. The availability of over-the-counter hormonal contraceptives and government initiatives promoting free access to birth control are also expected to stimulate demand for hormonal contraceptives. Additionally, the trend of delaying childbirth and starting a family at a later age is contributing to the market’s revenue growth in this region.
Get in detailed Research Study @ https://www.reportsanddata.com/report-detail/hormonal-contraceptive-market
For the purpose of this report, Reports and Data has segmented the global hormonal contraceptive market on the basis of Type Outlook, Hormone Outlook, and Regional Outlook:
Type Outlook (Revenue, USD Billion; 2022 – 2032)
- Pills
- Injections
- Vaginal Rings
- Transdermal Patches
- Others
Hormone Outlook (Revenue, USD Billion; 2022 – 2032)
- Combination Hormonal Contraceptives
- Progestin-Only Hormonal Contraceptives
Download Summary @ https://www.reportsanddata.com/download-summary-form/6379
Regional Outlook (Revenue, USD Billion; 2022-2032)
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- U.K.
- France
- Italy
- Spain
- Sweden
- BENELUX
- Rest of Europe
- Asia-Pacific
- China
- India
- Japan
- South Korea
- Rest of APAC
- Latin America
- Brazil
- Rest of LATAM
- Middle East & Africa
- Saudi Arabia
- UAE
- South Africa
- Israel
- Rest of MEA
Ask for Customize Research Report @ https://www.reportsanddata.com/request-customization-form/6379
Some points on how the report benefits stakeholders:
- The reports include historical (2020–2021) and forecast (2022–2032) data points, revenues, and CAGR in table, figure, and chart formats, with detailed and qualitative, supporting written information for each.
- Revenue break-up is provided for each segment in these formats for global, regional, and for each country in the respective region for each year between 2019 and 2030.
- The report contains insights regarding growth drivers, restraints, opportunities, trends, company profiles, strategic developments, expansion details, product launches, and various other aspects related to the market.
- The report contains data and information on customers, competitors, vendors/distributors, and other players and in the global marketplace.
- Market research analysis is vital for all crucial business strategies and can aid in numerous ways and to provide a clearer understanding about strategies being deployed by competitors, product launches, competitive analysis, technological advancements and various other factors that enhance sales of a firm or perhaps provide insights to focus on merger and acquisition as a strategy or enter into strategic agreements or joint ventures etc.
- The report contains company profiles of the top companies operating in the market along with their respective revenue and operating segments, geographical reach, market footprint, headquarters, growth rates, recent developments, product /services, expansion strategies, investments in expansion, and more.
Explore Latest Trending Research Reports By Reports and Data’s
Electroencephalography (EEG) Devices Market By Product Type (Amplifiers, Electrodes, Caps, Others), By End-use (Hospitals, Clinics, Research Centers, Others), By Region Forecast to 2032
Medical Scheduling Software Market, By Type (Web-based, Cloud-based, and On-premise), By End-use (Hospitals, Clinics, Diagnostic Centers, and Others), and By Region Forecast to 2032
Hemoglobinopathies Market, By Type (Sickle Cell Anemia, Thalassemia, and Others), By Treatment Type (Blood Transfusion, Bone Marrow Transplantation, Gene Therapy, and Others), and by Region Forecast to 2032
Medical Imaging Systems Market, By Product Type [X-ray, Computed Tomography (CT), Magnetic Resonance Imaging (MRI), Ultrasound, Nuclear Imaging, and Others], By End-use (Hospitals, Diagnostic Imaging Centers, and Others), and By Region Forecast to 2032
Auditory Brainstem Implant (ABI) Market By Type (Unilateral, Bilateral), By End-use (Adults, Pediatrics), By Region Forecast to 2032
Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market, By Treatment Type [Corticosteroids, Intravenous Immunoglobulin (IVIG), Thrombopoietin Receptor Agonists, Splenectomy, and Others], By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and By Region Forecast to 2032
Medical Waste Management Market, By Type of Waste (Hazardous, Non-Hazardous, and Infectious), By Treatment (Incineration, Autoclaving, Chemical Treatment, and Others), By Service Type (Onsite and Offsite), By Treatment Site (Hospitals, Pharmaceutical & Biotech Companies, and Others), and By Region Forecast to 2032
Sepsis Diagnostics Market, By Product Type (Blood Culture Media, Assay Kits & Reagents, Instruments, and Software), By Technology (Microbiology, Molecular Diagnostics, Immunoassays, and Flow Cytometry), By Method, By End-Use, and By Region Forecast to 2032
Cell Isolation Market By Product Type (Reagents & Kits, Instruments, Consumables), By Cell Type (Human Cells, Animal Cells), By Application (Biomolecule Isolation, Cancer Research, Stem Cell Research, Tissue Regeneration & Regenerative Medicine, Others), and By Region Forecast to 2032
Multiple Sclerosis Therapeutics Market By Product Type (Immunomodulators, Immunosuppressants), By Mode of Administration (Injectable, Oral), By Distribution Channel (Hospital Pharmacies, Online Pharmacies), and By Region Forecast to 2030
About Reports and Data
Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients to make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Products, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.
Contact Us:
John W
(Head of Business Development)
Reports and Data | Web: www.reportsanddata.com
Direct Line: +1-212-710-1370
E-mail: sales@reportsanddata.com
Blogs | Press Release | Industry News | Our competencies
Browse More Upcoming Reports @ https://www.reportsanddata.com/upcoming-reports
Browse More Latest Reports @ https://www.reportsanddata.com/report
Read Latest Press Release @ https://www.reportsanddata.com/press-release/global-hormonal-contraceptive-market